DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹358 Cr | ₹239 Cr | ₹345 Cr | ₹292 Cr | ₹226 Cr |
What is the latest Consolidated Net Profit of DR LAL PATHLABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹358 Cr |
| Mar2024 | ₹239 Cr |
| Mar2023 | ₹345 Cr |
| Mar2022 | ₹292 Cr |
| Mar2021 | ₹226 Cr |
How is Consolidated Net Profit of DR LAL PATHLABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹358 Cr | 49.78 | |
| Mar2024 | ₹239 Cr | -30.74 | |
| Mar2023 | ₹345 Cr | 18.25 | |
| Mar2022 | ₹292 Cr | 29.07 | |
| Mar2021 | ₹226 Cr | - | |
Compare Consolidated Net Profit of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹22,465.9 Cr | -2.7% | -6.6% | 4.1% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹107,736.0 Cr | -3.9% | -0.6% | 22.8% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹94,394.9 Cr | -7% | -8.7% | 2.7% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹61,049.7 Cr | -8.2% | -12.9% | 35.2% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹33,534.6 Cr | -6.2% | -12% | 5.3% | Stock Analytics | |
| GLOBAL HEALTH | ₹27,977.1 Cr | -5.9% | -9.2% | -11.4% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | -2.7% |
-6.6% |
4.1% |
| SENSEX | -2.7% |
-10.4% |
1.6% |
You may also like the below Video Courses